FHIR and the Future of Digital Labeling: What Manufacturers Need to Know
FHIR and the Future of Digital Labeling | LexisNexis Reed
LexisNexis Reed hosted a webinar to discuss the impact of FHIR on digital labeling.
Summary
LexisNexis Reed Tech explains that FHIR is emerging as a key framework for exchanging product labeling information, driven by regulatory authorities and health systems pushing digital transformation. The webinar details how FHIR impacts medical device and pharmaceutical manufacturers, covering everything from electronic labeling (eLabeling) to streamlining updates across jurisdictions.
Key Players
Details
As regulatory authorities and health systems push toward digital transformation, Fast Healthcare Interoperability Resources (FHIR) is emerging as a key framework for enabling the exchange of health data, including product labeling information. Experts from LexisNexis Reed Tech will break down FHIR's implications for medical device and pharmaceutical manufacturers. The discussion covers how FHIR enhances electronic labeling (eLabeling) and streamlines updates across different jurisdictions, fundamentally changing how labeling content is created, managed, and delivered. Key topics include: what FHIR is and its global adoption in health authority systems; its impact on Unique Device Identification (UDI) and Structured Product Labeling (SPL); and the role of FHIR in improving efficiency, traceability, and compliance. The session provides actionable insights for regulatory affairs professionals, labeling managers, IT stakeholders, and compliance officers.
Technology Note
FHIR（Fast Healthcare Interoperability Resources）は医療データ交換の国際標準。このエントリの関連技術: FHIR
Original content copyright by respective publishers